Pharma and Biotech
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 21-Nov-2024 | 10:15 | RNS |
Form 8.3 - Benchmark Holdings plc | 21-Nov-2024 | 07:00 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 20-Nov-2024 | 09:53 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 15-Nov-2024 | 09:21 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 14-Nov-2024 | 09:18 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 13-Nov-2024 | 09:48 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 12-Nov-2024 | 09:39 | RNS |
Form 8.3 - Benchmark Holdings Plc | 12-Nov-2024 | 07:00 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 07-Nov-2024 | 09:27 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 06-Nov-2024 | 09:25 | RNS |
Rule 2.9 Announcement | 05-Nov-2024 | 10:00 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 05-Nov-2024 | 09:21 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 31-Oct-2024 | 09:57 | RNS |
Total Voting Rights | 31-Oct-2024 | 07:00 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 30-Oct-2024 | 11:08 | RNS |
Currency | UK Pounds |
Share Price | 35.60p |
Change Today | -3.40p |
% Change | -8.72 % |
52 Week High | 48.00 |
52 Week Low | 34.00 |
Volume | 118,205 |
Shares Issued | 739.79m |
Market Cap | £263.37m |
Beta | 0.48 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
13:45 | 3 @ 35.64p |
12:40 | 44 @ 36.00p |
11:41 | 5,682 @ 36.00p |
11:41 | 6,318 @ 36.00p |
11:38 | 7,236 @ 35.61p |
Chair | Peter George |
CFO | Septima Maguire |
CEO | Trond Williksen |
You are here: research